Literature DB >> 3556210

Seroepidemiological study on sexually transmitted diseases and hepatitis B in African promiscuous heterosexuals in relation to HTLV-III infection.

P Van de Perre, N Clumeck, M Steens, G Zissis, M Caraël, R Lagasse, S De Wit, T Lafontaine, P De Mol, J P Butzler.   

Abstract

A seroepidemiological study was performed on HTLV-III, T. pallidum, C. trachomatis and Hepatitis B virus (HBV), in Butare, Rwanda, among 33 female prostitutes, 25 male customers of prostitutes, and 60 male and female controls. As compared with female controls the prostitutes had a higher prevalence of antibodies to HTLV-III (29/33 versus 4/33, p less than 0.001), T. pallidum (TPHA: 27/33 versus 6/33, p less than 0.001; RPR: 19/33 versus 2/33, p less than 0.001; FTA-Abs: 27/33 versus 5/33, p less than 0.001) and C. trachomatis (IgG IF: 31/33 versus 13/33, p less than 0.001). HBV serological markers were more often detected in the prostitutes than in the female controls (31/33 versus 18/33, p less than 0.001) although HBs antigen carriage rate was similar in both groups. As compared with male controls, the male customers of prostitutes had more frequently detectable antibodies to HTLV-III (7/25 versus 2/27, p = 0.05), and a positive RPR (10/25 versus 1/27, p less than 0.01). Among the 118 individuals studied, odds ratios and trend analysis disclosed a significant association between HTLV-III seropositivity and a positive TPHA, RPR, FTA-Abs, Chlamydia IgG IF test and serological markers to HBV. No association was found between HTLV-III seropositivity and HBs Ag carriage. This study suggests that HTLV-III has to be considered as an infectious agent transmitted among promiscuous Central African heterosexuals by sexual contact and/or parenteral contact with unsterile needles used for STD treatments.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Antibodies--analysis; Behavior; Biology; Chlamydia; Data Analysis; Developing Countries; Diseases; Eastern Africa; Examinations And Diagnoses; French Speaking Africa; Hepatic Effects; Hiv Infections; Immunity; Immunologic Factors; Infections; Laboratory Examinations And Diagnoses; Measurement; Physiology; Prevalence; Prostitutes; Reproductive Tract Infections; Research Methodology; Rwanda; Sex Behavior; Sexually Transmitted Diseases; Viral Diseases

Mesh:

Substances:

Year:  1987        PMID: 3556210     DOI: 10.1007/BF00145066

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  18 in total

1.  Outbreak of serum hepatitis associated with tattooing.

Authors:  N A Mowat; P W Brunt; F Albert-Recht; W Walker
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

2.  Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis.

Authors:  G M Levene; J L Turk; D J Wright; A G Grimble
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

3.  Hemagglutination tests for diagnosis of syphilis. A preliminary report.

Authors:  T Tomizawa
Journal:  Jpn J Med Sci Biol       Date:  1966-12

4.  Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis.

Authors:  W E Deacon; J B Lucas; E V Price
Journal:  JAMA       Date:  1966-11-07       Impact factor: 56.272

5.  Role of hepatitis B virus in acquired immunodeficiency syndrome.

Authors:  R T Ravenholt
Journal:  Lancet       Date:  1983-10-15       Impact factor: 79.321

6.  Antibody to HTLV-III in blood donors in central Africa.

Authors:  P Van de Perre; D Munyambuga; G Zissis; J P Butlzer; D Nzaramba; N Clumeck
Journal:  Lancet       Date:  1985-02-09       Impact factor: 79.321

7.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

8.  Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal.

Authors:  F Barin; J Perrin; J Chotard; F Denis; R N'Doye; I Diop Mar; J P Chiron; P Coursaget; A Goudeau; P Maupas
Journal:  Prog Med Virol       Date:  1981

9.  Heterosexual promiscuity among African patients with AIDS.

Authors:  N Clumck; P Van de Perre; M Caral; D Rouvroy; D Nzaramba
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

10.  Acquired immunodeficiency syndrome in a heterosexual population in Zaire.

Authors:  P Piot; T C Quinn; H Taelman; F M Feinsod; K B Minlangu; O Wobin; N Mbendi; P Mazebo; K Ndangi; W Stevens
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

View more
  7 in total

Review 1.  Immunological functions of the human prepuce.

Authors:  P M Fleiss; F M Hodges; R S Van Howe
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

2.  Hepatitis B virus and sexual behavior in Rakai, Uganda.

Authors:  Lara Stabinski; Steven J Reynolds; Ponsiano Ocama; Oliver Laeyendecker; David Serwadda; Ron H Gray; Maria Wawer; David L Thomas; Thomas C Quinn; Gregory D Kirk
Journal:  J Med Virol       Date:  2011-05       Impact factor: 2.327

3.  Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Authors:  N C Pedersen; M Torten; B Rideout; E Sparger; T Tonachini; P A Luciw; C Ackley; N Levy; J Yamamoto
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus.

Authors:  P Van de Perre; A De Clercq; J Cogniaux-Leclerc; D Nzaramba; J P Butzler; S Sprecher-Goldberger
Journal:  Genitourin Med       Date:  1988-02

5.  Evaluation of seroepidemiological associations between HIV-infection, hepatitis B and other sexually transmitted diseases in African patients.

Authors:  J ter Meulen; K M Wittkowski; J J Kidenya; M Pöllath; R Dörries; K Fleischer; K Dietz; V ter Meulen
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

6.  Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.

Authors:  Shelina Moonsamy; Melinda Suchard; Pavitra Pillay; Nishi Prabdial-Sing
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 3.295

7.  A systematic review to describe patterns of animal and human viral research in Rwanda.

Authors:  M Fausta Dutuze; Maurice Byukusenge; Anselme Shyaka; Rebecca C Christofferson
Journal:  Int Health       Date:  2022-06-01       Impact factor: 3.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.